WHO gives Sinopharm jab emergency approval

By Stephanie Nebehay
Updated May 8 2021 - 1:14pm, first published 1:08pm
WHO approval opens the door to Sinopharm shipments being delivered through the COVAX initiative.
WHO approval opens the door to Sinopharm shipments being delivered through the COVAX initiative.

The World Health Organisation approved for emergency use a COVID-19 vaccine from China's state-owned drug maker Sinopharm, bolstering Beijing's push for a bigger role in inoculating the world.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Goulburn news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.